Top Markets
Coin of the day
MabCure Inc. MabCure Inc.

MabCure Inc.

MBCI
Rang in Aktien #41405
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Aktienkurs
$0.0003
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$21.97K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
200.00%
Land
US
Handel MabCure Inc. (MBCI)

Kategorie

Dividendenrendite-Verlauf für MabCure Inc. (MBCI)
Dividendenrendite (TTM) von MabCure Inc. (Aktienkürzel: MBCI) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für MabCure Inc. (MBCI) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber